Corum Group Ltd logo

Corum Group Ltd (COO)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
0.12% Div Yield
62,975 Volume
- Eps
Want to track COO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

COO closed Tuesday higher, an increase of 2.33% from Monday's close, completing a monthly increase of 0%. Over the past 12 months, COO stock gained 0%.
COO pays dividends to its shareholders, with the most recent payment made on Feb 23, 2015. The next estimated payment will be in 23 Feb 2015 on Feb 23, 2015 for a total of A$0.00474.
The last earnings report, released on Aug 31, 2016, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Corum Group Ltd has completed 3 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

Seekingalpha | 8 hours ago
The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 10 hours ago
The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago.

Zacks | 11 hours ago

Corum Group Ltd (COO) FAQ

On which exchange is it traded?

Corum Group Ltd is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is COO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, no market cap data is available.

Has Corum Group Ltd ever had a stock split?

Corum Group Ltd had 3 splits and the recent split was on Feb 20, 2024.

Corum Group Ltd Profile

- Industry
- Sector
Albert G. White III CEO
ASX Exchange
AU000000COO1 ISIN
US Country
16,000 Employees
26 Jul 2023 Last Dividend
20 Feb 2024 Last Split
- IPO Date

Overview

The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.

Products and Services

CooperVision:

  • Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
  • Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.

CooperSurgical:

  • Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
  • Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
  • Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
  • Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.

Contact Information

Address: 6101 Bollinger Canyon Road
Phone: 925 460 3600